Opus Genetics, Inc. (IRD) Shareholders’ equity 2019–2025
Opus Genetics, Inc. (IRD) shareholders’ equity at each fiscal year-end, per SEC filings.
$15.3MFY2025 · since FY2019: -$7.6M → $15.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.3M | +128.3% |
| FY2024 | $6.7M | -86.5% |
| FY2023 | $49.9M | +7.9% |
| FY2022 | $46.2M | +108.1% |
| FY2021 | $22.2M | +265.0% |
| FY2020 | -$13.5M | -78.1% |
| FY2019 | -$7.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice